In short. Transferring the patient's own fat is the surgical volume route to a temple: its staging, its unpredictable take, and why it is a later rung not a default.

Key points

  • The donor site is part of the procedure.
  • It has its own bruising, its own discomfort and occasionally its own scar, and it heals on its own timetable.
  • A patient told about the temple and not about the donor area has been told about half of what the operation involves.

The surgical route to a hollow temple takes fat from somewhere else on the body and places it into the deep compartment of the region. It is a legitimate answer with a long history, and the rung where the conversation changes from a visit to an operation. It sits last on this site's ladder for practical reasons, not hierarchical ones.

What it is

Fat is removed from a donor area, prepared, and placed into the temple. Unlike an injectable, what is placed is the patient's own tissue, and part of it establishes a blood supply and remains. That is what gives the route its appeal and also what makes it less predictable: how much remains is not fully within anyone's control.

Who it suits

It is a reasonable conversation where a large volume is needed, where a long duration is the priority, where a face has lost fat generally and the temple is one of several regions treated, or where injections have been used and the result, though correct, has not lasted as long as the patient wanted.

Who it does not suit

Where the hollow is a stable shape rather than a loss, because there is nothing to restore. Where the face is still losing weight, because the fat placed will be subject to the process that removed the original. Where a small correction is all that is wanted, because an operation is disproportionate to it. And where the expectation is that the result will be exact.

Two areas, not one

The donor site is part of the procedure. It has its own bruising, its own discomfort and occasionally its own scar, and it heals on its own timetable. A patient told about the temple and not about the donor area has been told about half of what the operation involves.

Staging and recovery

Swelling settles over weeks rather than days, and the contour is judged at several months, because the fat that survives does so over that period. A second stage, where planned, is usually arranged after that interval, so the decision rests on the settled result.

The honest ceiling

This route restores volume and does not restore bone. Where the temporal fossa is narrow or deeply set, the same ceiling applies as to any volume route: the frame beneath the tissue has not changed, and no amount of fat placed above it alters that.

What to establish before agreeing to an operation

  • Where the fat will be taken from, and what that area involves during recovery.
  • Whether more than one stage is anticipated, and on what basis that judgement is made.
  • What happens if the result is uneven, and what a revision would entail.

What volume can and cannot change by any route is set out in the limits of volume. The presentation where the real problem is not volume is described in when volume is not the problem, and the anatomy that makes this region careful is covered in the anatomy that decides the plan.

Related reading

Frequently asked questions

Why is fat transfer not the first choice for a hollow temple?

Because it is an operation with a donor site, an anaesthetic, a recovery and a take that cannot be predicted exactly, and because the same region can often be treated by an injection with far less of all four. It becomes the reasonable rung where a large volume is needed, where a long duration is wanted, where injections have been tried and were unsatisfactory, or where the patient prefers a single procedure to a series.

What does the donor site involve?

Fat is taken from somewhere else on the body, most often the abdomen or the thigh, which means a second area with its own bruising, tenderness and, in some cases, a small scar. That second area is part of the recovery and is often left out of the conversation, which is why it is named here. The donor site settles over weeks and is usually the more uncomfortable of the two in the days afterwards.

Is the result predictable?

Less than any injectable. A proportion of the transferred fat does not survive, the amount varies between individuals and between areas, and the final contour is judged after several months rather than after several weeks. Some clinicians plan for a second stage for this reason, and a plan that mentions only one is a plan that has left something out.

Risks & Limitations

  • Material placed into a named vessel in this region can travel and cause damage at a distance; this is uncommon and serious when it happens.
  • The branch of the facial nerve that lifts the brow runs superficially here, and injury to it can produce brow weakness that may not fully recover.
  • Bruising and swelling in this region are common and are more visible than the size of the area suggests; the result is judged months later, not at ten days.
  • Overfilling is visible here earlier than on the cheek, because the region is shallow and its borders are close.
  • A transfer of the patient's own fat is less predictable than an injectable, and more than one stage may be needed.

When to Seek Care

  • Severe or increasing pain, a tense swollen area, or skin that is blistering or changing colour — seek urgent care.
  • Blurred vision, loss of vision, or pain behind the eye — seek emergency care immediately.
  • Weakness on one side of the face, or spreading redness with fever.
  • Hollowing on one side only, or a change that appeared over weeks, which needs a medical assessment first.

References & Further Reading

  • American Society of Plastic Surgeons (ASPS) — facial aesthetic surgery and safety guidance
  • International Society of Aesthetic Plastic Surgery (ISAPS) — global procedure and safety resources
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
  • Cochrane Library — systematic reviews
  • Chinese Medical Association Plastic Surgery Branch — clinical guidance

Medically reviewed by Tongchun Mao, MD (毛彤春), Deputy Director & Head of Aesthetic Surgery. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.